Guideline on the requirements of external quality assessment programs in molecular pathology

The Genetic Basis for Cancer Treatment Decisions

(2012) Janet E. Dancey et al.   CELL

The UK NEQAS for Molecular Genetics scheme for gastrointestinal stromal tumour: findings and recommendations following four rounds of circulation: Table 1

(2012) Newton A C S Wong et al.   JOURNAL OF CLINICAL PATHOLOGY

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy

(2011) E. Thunnissen et al.   JOURNAL OF CLINICAL PATHOLOGY

External Quality Assessment for KRAS Testing Is Needed: Setup of a European Program and Report of the First Joined Regional Quality Assessment Rounds

(2011) E. Bellon et al.   ONCOLOGIST

Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme

(2011) Elisabeth Dequeker et al.   VIRCHOWS ARCHIV

EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC

(2010) Roland Penzel et al.   VIRCHOWS ARCHIV

Implementation of External Quality Assurance Trials for Immunohistochemically Determined Breast Cancer Biomarkers in Germany

(2008) Reinhard Von Wasielewski et al.   Breast Care